respiratory distress syndrome

Based on prior clinical data, the 'Fast Assessment of Lung Maturity at Birth' study demonstrates that measuring lung maturity biomarkers, AI can predict Respiratory Distress Syndrome (RDS) with high accuracy (91% sensitivity) moments after birth.

Evaluation of a Ventilation Strategy to Prevent Barotrauma in Patients at High Risk for Acute Respiratory Distress Syndrome. N Engl J Med 1998; 338: 355-61.

Acute respiratory distress syndrome: The Berlin definition.

Direct causes of acute respiratory distress syndrome were pneumonia and aspiration together contributing to 43.75% of patients.

Clinical trials in acute respiratory distress syndrome: challenges and opportunities.

High-frequency oscillation for acute respiratory distress syndrome. N Engl J Med.

reported evidence on the benefits of vitamin D for respiratory distress syndrome treatment and prevention.

Background: Acute respiratory distress syndrome (ARDS) is a severe inflammatory condition.

Objective: To analyze the therapeutic effect of pulmonary surfactant (PS) in combination with nasal continuous positive airway pressure (NCPAP) therapy on neonatal respiratory distress syndrome (NRDS).

Acute respiratory distress syndrome (ARDS) is a catastrophic syndrome commonly seen among intensive care unit patients, with a fatality rate of 27-45% (1).

Respiratory distress syndrome (RDS) occurs mainly in preterm infants and its incidence is inversely correlated with gestational age and birth weight.

A typical therapeutic protocol of severe acute respiratory distress syndrome (ARDS) is shown in Figure 1 [9].

In acute respiratory distress syndrome (ARDS), BPFs can cause incomplete lung expansion, loss of effective tidal volume and positive end expiratory pressure (PEEP), and reduced carbon dioxide elimination [5].

Indications for applying NB-CPAP were transient tachypnea of the newborn (TTN, 52%) and respiratory distress syndrome (RDS, 44%).

(6) In 1967, Ashbaugh et al (1) coined the now well-known term acute respiratory distress syndrome to describe a clinical syndrome characterized by "an acute onset of tachypnea, hypoxaemia, and loss of compliance after a variety of stimuli." In 1994, the American-European Consensus Conferences (AECC) on ARDS published a statement on definitions, mechanisms, relevant outcomes, and clinical trial coordination (7) that attempted to delineate and guide treatment; however, there remained some confusion due to overlapping criteria applied to the definition of ALI and ARDS, specifically in relation to hypoxia levels and imaging interpretation.